Rizwana F. Sproule, VP Regulatory Affairs at Kite Pharma, Inc. (KITE), sold 9,567 shares at $52.27 ($531K) on 2016-01-15, disclosed to the SEC on 2016-01-19.
Open-market sale of $531k KITE by VP Regulatory Affairs. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.27 | 271 | $14K | 2.7% |
| 2 | $53.89 | 645 | $35K | 6.5% |
| 3 | $55.07 | 3,166 | $174K | 32.8% |
| 4 | $55.60 | 1,918 | $107K | 20.1% |
| 5 | $57.09 | 800 | $46K | 8.6% |
| 6 | $53.55 | 497 |
| $27K |
| 5.0% |
| 7 | $54.58 | 355 | $19K | 3.7% |
| 8 | $55.67 | 635 | $35K | 6.7% |
| 9 | $56.70 | 230 | $13K | 2.5% |
| 10 | $57.74 | 852 | $49K | 9.3% |
| 11 | $58.92 | 198 | $12K | 2.2% |
| Total | $55.49 avg | 9,567 | $531K | 100% |
| Filing → |
| KITE | SELL | 2015-12-17 | $610K | — | Filing → |
| KITE | SELL | 2015-11-18 | $748K | — | Filing → |
| KITE | SELL | 2015-10-19 | $599K | — | Filing → |